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Characterising opportunity to use heroin reveals new avenues for intervention:  1 
context, outcomes, and latency to initiation 2 
Abstract 3 
Preceding initiation, opportunity to use heroin is the earliest necessary condition for heroin 4 
related outcomes to occur. This study aimed to characterise first heroin use opportunity (prior 5 
to initiation), and to identify heroin-related outcomes associated with earlier age at first 6 
opportunity. Structured interviews were conducted with 93 opiate substitution treatment 7 
clients in UK drug and alcohol treatment clinics. The majority of participants (64.8%) 8 
reported initiating heroin use on the same day as being first presented with the opportunity to 9 
use heroin. Of those who reported early age at opportunity to use heroin, 77.4% reported this 10 
came from friends/partner/family compared to 59.3% of those who reported later 11 
opportunities. After adjustment, overdose was found to be more than twice as likely amongst 12 
those who reported first opportunity to use heroin at age 17 or under (AOR 2.82 95% CI 1.57 13 
- 5.05). Findings indicate the early drug use environment is linked to later risk of overdose. 14 
Greater consideration of context surrounding heroin use opportunity may indicate 15 
mechanisms to disrupt or prevent initiation of heroin use and later drug-related harms. Given 16 
short latency to initiation, focus should be placed on preventing initiation of heroin use 17 
through injecting. 18 
Introduction 19 
Dependence on heroin and other opioids accounts for the highest proportion of the illicit drug 20 
contribution to Disability Adjusted Life Years (Degenhardt, Whiteford, & Hall, 2014). This is 21 
despite low prevalence of use in general population samples (UNODC, 2014). Aside from 22 
dependence, heroin use is associated with a number of significant health risks. Overdose is 23 
the leading cause of mortality amongst those who use this drug (Degenhardt et al., 2011), 24 
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whilst the administration of heroin through injection increases risks for blood borne virus 1 
transmission through syringe sharing (Strang et al., 1998). 2 
These harms cannot occur amongst individuals who do not have the opportunity to use heroin 3 
(Hines, Morley, Mackie, & Lynskey, 2015). The first stage of drug involvement is having the 4 
opportunity to use a drug (regardless of whether the individual uses the drug or not). Having 5 
the opportunity to use a drug is distinct from initiation of drug use, and has been previously 6 
defined in the literature as an individual being offered a drug, or being present when others 7 
were using so that an individual could have used it if they had wanted to (Storr, Wagner, 8 
Chen, & Anthony, 2011). The first opportunity to use a drug forms an individual’s earliest 9 
necessary condition from which they are at risk of developing dependence (Wagner & 10 
Anthony, 2002a), but having the opportunity to use a drug does not equate to an individual 11 
initiating use. For example, research has identified a significant minority who report having 12 
the opportunity to use cannabis, but do not report having used cannabis (Hines et al., 2016). 13 
Following on from opportunity, an individual may initiate drug use, and can progress to 14 
subsequent use and regular drug use.  15 
Research into drug use is increasingly exploring variation in drug opportunity to understand 16 
the mechanisms underlying initiation of use and development of dependence (Burdzovic 17 
Andreas & Bretteville-Jensen, 2017, 2018; Hines et al., 2016; Wagner & Anthony, 2002b). 18 
Focus in this area can provide insight into the pathways through which drug use develops. 19 
Additionally, there is a need to understand the context of opportunities, such as the age at 20 
which they occur and the people who are providing them, to inform interventions that target 21 
the primary mechanisms progressing drug use (Fink, 2017). Considering the opportunity to 22 
use heroin (preceding initiation of use) and the context in which it occurs may help to inform 23 
interventions to prevent initiation of use and the spread of injecting. 24 
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To date, no research has considered heroin opportunity as distinct from initiation of heroin 1 
use. We know that initiation of drug use at earlier ages is commonly associated with 2 
increased risks of substance use disorder development (Swift, Coffey, Carlin, Degenhardt, & 3 
Patton, 2008), and that younger age of starting to use heroin is associated with increased rates 4 
of non-fatal overdose (Lynskey & Hall, 1998). However, research has not established when 5 
first opportunity to use heroin typically occurs, who provides those opportunities, and 6 
whether the timing of heroin use opportunity (preceding initiation) is associated with greater 7 
risk of harms once use has been initiated. 8 
The low prevalence of heroin opportunity and use in longitudinal, general population samples 9 
(Allen et al., 2017; Van Etten & Anthony, 1999) necessitates the use of populations in contact 10 
with clinical services to study heroin use, which leads to low variation in dependence status 11 
of the samples. However, using a treatment sample allows exploration of the latency from 12 
heroin opportunity to initiation, networks through which heroin opportunity is provided, and 13 
heroin-related harms associated with earlier opportunity (preceding initiation). To this end, a 14 
sample of individuals in treatment for their heroin use were recruited to address the following 15 
aims: 16 
1. Characterise first opportunity to use heroin (preceding initiation) in a treatment-17 
seeking sample 18 
2. Identify relationship between timing of opportunity and latency of progression to 19 
initiation, injection onset and daily use. 20 
3. Identify demographic factors and heroin-use outcomes associated with age of 21 






Data collection took place in two UK drug and alcohol treatment services within the South 1 
London and Maudsley NHS Foundation Trust (SLAM). In total, 93 participants were 2 
recruited into the study; with a participant response rate of 89%. Participants provided 3 
responses to a short structured quantitative interview administered by a researcher, and were 4 
reimbursed £10 upon interview completion. All responses were provided through self-report. 5 
Ethical approval 6 
Ethical approval was granted by the NHS Research Ethics Committee (15 /LO/0705) and 7 
SLAM Research and Development. 8 
Measures 9 
Age of First Opportunity to Use Heroin 10 
Respondents were asked to specify the age (in years) at which they first had the opportunity 11 
to use heroin, whether or not they actually used heroin at that time. To improve 12 
understanding, participants were given the following prompt: “By an opportunity I mean 13 
someone either offered you heroin, or you were present when others were using and you 14 
could have used if you wanted to” (Storr et al., 2011). 15 
Early and Later Opportunity to Use Heroin 16 
Due to the non-normal distribution of age of first opportunity to use heroin, the continuous 17 
age measure of this item was transformed into tertiles. Participants who were in the lowest 18 
tertile, reporting opportunity to use heroin at age 17 or under, were classified as experiencing 19 
early opportunity. Those aged 18 or over were classified as experiencing later opportunity to 20 
use heroin. 21 
Heroin Outcomes 22 
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Participants self-reported whether they had ever experienced overdose. Information on the 1 
amount of heroin used was collected through the item “At your period of heaviest use, what 2 
amount of heroin/opiates were you using on a typical day?” Participants were asked to 3 
respond with an amount in grams and/or in pounds sterling (£).  To combine response in £ 4 
and responses in grams, the continuous age measure of both these items was transformed into 5 
tertiles. Participants who were in the highest tertile for reported amount in grams or in £ were 6 
classified as reporting heroin heavy use. 7 
Onset of Heroin Use Behaviours Following First Opportunity 8 
Participants self-reported their age at initiation of heroin use, age at initiation of injecting 9 
heroin, age at onset of daily heroin use, and the length of time between having the first 10 
opportunity to use heroin (preceding initiation) and initiating heroin use. Participants 11 
provided responses in days, weeks, months or years. These responses were coded to a 12 
categorical variable of “initiated use same day”, “initiated use within 1-7 days”, “initiated use 13 
between one week and one month following opportunity”, “initiation within the same year as 14 
opportunity” and “initiation more than a year after opportunity”. 15 
Contextual factors 16 
Participants were asked who they were with when they first had the opportunity to use heroin. 17 
Participants selected from the options spouse/partner/boyfriend/girlfriend, parent, step or 18 
foster parent, sibling, other relative, friend, acquaintance, stranger; due to low group numbers 19 
the variable was collapsed into stranger/acquaintance, friend/partner, or family. Participants 20 
who spontaneously reported being alone at first opportunity (N=4) were coded as missing. 21 
Demographic variables 22 
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Participants self-reported their gender, ethnicity (collapsed into the categories White British, 1 
Other White, and Black and Minority Ethnic (BME) Groups), highest level of education 2 
completed, and age at interview. 3 
Analysis 4 
Associations between age of first opportunity to use heroin (preceding initiation) and 5 
demographic, contextual and heroin outcome factors were initially assessed through t-test and 6 
chi square analysis (or fishers exact test when group N <5). Associations between the 7 
exposure age of opportunity to use heroin and heroin outcomes that were identified as 8 
significant (P=<0.05) were further assessed through univariate logistic and linear regression 9 
(logistic regression for binary outcomes provides an Odds Ratio (OR) as measure of effect, 10 
and linear regression for continuous outcomes provides a Beta coefficient (Beta) as measure 11 
of effect). Multivariable regression adjusted for age at interview and age of initiation, serving 12 
as a proxy for adjustment for duration of heroin use. The Huber-White estimator was applied 13 
to all models to account for clustering of observations from the same clinic. 14 
Results 15 
Sample Description 16 
This sample of participants in treatment for their heroin use were predominately male 17 
(74.2%) and White British (55.9%), with a high school education or lower (67.8%). The 18 
mean age of initiation of heroin use (following opportunity) was 22.6 (95% CI 21.1 – 24.1), 19 
mean age of injecting onset was 26.1 (95% CI 24.3 – 27.9), and mean age at onset of daily 20 
heroin use was 25 (95% CI 23.2 – 26.6). Lifetime heavy heroin use was reported by 36.4% of 21 
the sample, and lifetime overdose reported by 54.8% of the sample. See Tables 1 and 2 for 22 
complete data. 23 
[Table 1 near here] 24 
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Characterising First Opportunity to use Heroin (preceding initiation) 1 
The mean age of first opportunity to use heroin (preceding initiation of use) was 21.5 (SD = 2 
7.08), with a range of 8-42 years. The majority of participants reported initiating heroin use 3 
on the same day as having their first opportunity to use. Amongst those who did not 4 
immediately initiate use following this first opportunity, initiation of heroin use was most 5 
commonly over a year later, or was within the 2-12 months following opportunity. Over half 6 
of participants reported that their first opportunity to use heroin was provided by a 7 
friend/partner, over a third reported that their first opportunity to use heroin was provided by 8 
a stranger/acquaintance, and a minority reported their first opportunity to use heroin was 9 
provided by a family member. 10 
[Table 2 near here] 11 
Early Opportunity and Later Heroin Outcomes 12 
Of those who reported their age of first opportunity to use heroin, 34.4% (N=31) reported 13 
having their first opportunity at age 17 or under, and 65.6% (N=59) reported having their first 14 
opportunity to use heroin at age 18 or over. Between those reporting early and late 15 
opportunity there were significant differences in report of overdose, mean age of initiation of 16 
heroin use, mean age of injecting onset, and age of onset of daily heroin use. Between those 17 
reporting early opportunity to use heroin and those reporting later opportunity there were no 18 
significant differences in gender, ethnicity, education, who was present at their first heroin 19 
use opportunity (see Table 1), time from first opportunity to initiating heroin use, or 20 
heaviness of heroin use (see Table 2). However, it is notable that a much lower proportion of 21 
those who had early opportunity to use heroin compared to later opportunity to use heroin 22 
experienced this opportunity through strangers/acquaintances, indicating a trend towards 23 
friends/partner and family providing earlier heroin use opportunities.  24 
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Identified associations between age of first opportunity to use heroin and heroin-related 1 
outcomes were analysed through multivariable regression analysis, adjusting for age at 2 
interview and reported age at initiation of heroin use to act as a proxy for duration of use. 3 
After adjustment, early opportunity to use heroin was not associated with lower age of 4 
injecting onset and lower age of onset of daily heroin use (see Table 3). However, those who 5 
reported early opportunity to use heroin (preceding initiation) were more than twice as likely 6 
to report having experienced overdose after adjustment for duration of heroin use (see Table 7 
3). 8 
[Table 3 near here] 9 
Discussion 10 
This study is the first to characterise opportunity to use heroin (being offered heroin or being 11 
around individuals using the drug) as an event separate from and preceding the initiation of 12 
heroin use. Analysis of data collected from a treatment-seeking sample has identified 13 
variation in the age at which individuals report having had their first opportunity to use 14 
heroin. The majority of the sample reported initiating heroin use immediately following their 15 
first opportunity, but a sizeable minority of individuals report a delay of over a year between 16 
first having the opportunity to use heroin and initiating use. The majority of the sample report 17 
that their opportunity to use came through friends or partners. Those who report first 18 
opportunity to use heroin at age 17 and under have twice the likelihood of reporting overdose 19 
during their heroin use career. This association remained after controlling for age of initiation 20 
and duration of heroin use. After adjustment for age at initiation of use and duration of use, 21 
earlier opportunity to use heroin was not associated with age of injection onset and age at 22 
daily heroin use. 23 
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By collecting retrospective data on first opportunity to use heroin, this study has clearly 1 
differentiated the opportunity to use heroin as distinct from initiation of use. The majority of 2 
the sample reported initiating heroin use on the day of their first opportunity to use the drug 3 
(and it is plausible to assume initiation immediately followed this first opportunity). 4 
However, a third of the sample report a delay of weeks, months or years between their first 5 
opportunity to use heroin and initiating use. This study is the first to report variation in 6 
latency between opportunity and initiation of heroin use. Further study of this area may 7 
reveal prevention targets to disrupt progression from opportunity to initiation amongst those 8 
who experience a delay. However, over half the sample report initiating use immediately 9 
after having first opportunity to use; if this initiation is through injecting drug use, the 10 
transition to daily heroin use will be especially rapid (Hines et al., 2017). This suggests the 11 
most effective harm reduction approach would be policy level interventions to reduce uptake 12 
of injecting, such as altering policing to penalise the supply of injectable heroin whilst being 13 
more tolerant of the supply of heroin that could only be smoked (Strang & King, 1997). 14 
Opportunity to use heroin (distinct from initiation of heroin use) is a previously overlooked 15 
mechanism for intervention. However, the present analyses suggest consideration of this 16 
stage of drug use has utility for prevention; not only for disrupting heroin use initiation, but 17 
also for reducing overdose. The association between earlier opportunity to use heroin and 18 
increased likelihood of overdose – which remained after controlling for age of initiation and 19 
duration of heroin use - parallels findings that younger age of heroin initiation is associated 20 
with overdose (Lynskey & Hall, 1998). In line with recent calls to expand the concept of 21 
toxicity (Strang, Neale, McDonald, & Kalk, 2018), these findings suggest that the field may 22 
benefit from expanding our concept beyond pharmacology to consider motivations and risk 23 
behaviours underlying overdose. It is plausible that those who have earlier opportunity to use 24 
heroin are growing up in environments in which potentially dangerous drug use habits, such 25 
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as concomitant use of multiple drugs, will develop. Further exploring the mechanisms 1 
through which early drug use behaviours are linked to later drug use outcomes is a viable 2 
route to reveal overlooked targets for intervention. 3 
Targeting prevention messages and interventions at the families and networks of those 4 
involved in heroin use may be necessary to pre-emptively disrupt progression to initiation. It 5 
is notable that a greater proportion of those who experience early heroin opportunity report 6 
having this opportunity through friends/partner or their family, compared to 7 
strangers/acquaintances. Knowledge of where opportunities are arising may act as a 8 
mechanism to disrupt initiation of use (Fink, 2017). Previous qualitative research into 9 
friendship networks associated with heroin use has reported that these change as use develops 10 
(Best, Manning, & Strang, 2007), but no existing quantitative research has considered the 11 
effect of peers at the time of heroin exposure. Intervening with networks of people who inject 12 
drugs to discourage initiation of others into injecting (Hunt, Stillwell, Taylor, & Griffiths, 13 
1998) is one method through which this high-risk behaviour may be limited. 14 
Limitations of this study must be considered when interpreting the results. Data were 15 
collected on only a small number of potential covariates, and consequently detailed analysis 16 
of what may underlie the relationship between age of opportunity to use heroin and overdose 17 
cannot be conducted. The data were collected through self-report, which is unlikely to bias 18 
results in samples of people who inject drugs when recall is short-term (Darke, 1998). 19 
However, the use of retrospective self-report introduces the potential for recall bias to affect 20 
the results. Studies of cannabis, alcohol and tobacco have identified moderate reliability for 21 
self-reported age of onset (Ensminger, Juon, & Green, 2007; Huerta, Chodick, Balicer, 22 
Davidovitch, & Grotto, 2005; Parra, O’Neill, & Sher, 2003; Shillington, Cottler, Mager, & 23 
Compton III, 1995). The present findings would benefit from being replicated in prospective 24 
research, but this presents challenges given the low prevalence of heroin use in the general 25 
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population. The small sample size in this exploratory study may have led to limited power to 1 
detect significant associations, and precluded greater variation in the analysis of age of 2 
opportunity onset and time from opportunity to initiation. Additionally, the small sample 3 
precluded adjustment for potentially confounding variables beyond the continuous variables 4 
of age at heroin initiation and age at interview.  5 
Conclusions 6 
Considering opportunity to use heroin as an occurrence distinct from initiation of heroin use 7 
has identified an association between earlier opportunity to use heroin and later overdose, and 8 
has revealed that only a third of participants report a delay of weeks, months or years 9 
between opportunity and initiation. Two thirds of participants reported initiating heroin use 10 
on the same day as having their first opportunity to use the drug. Efforts to disrupt 11 
progression to heroin use initiation should focus on minimising drug use opportunity in high-12 
risk environments. Given the short latency from opportunity to initiation, more focus should 13 
be placed on preventing the initiation of heroin use through injecting routes to minimise 14 
harms.  15 
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Table 1: Chi square analysis of relationship between demographic and contextual factors and 1 





Whole sample  Early first 
opportunity 









% (N) % (N) % (N) 
Gender Male 74 (69) 77 (24) 73 (43) 0.72 
Ethnicity White British 56 (52) 58 (18) 56 (33) 0.65 
Other white 23 (21) 26 (8) 20 (12) 
BME 21 (20) 16 (5) 24 (14) 
Education Did not complete 
high school 
41 (38) 42 (13) 39 (23) 0.96 
High school 27 (25) 26 (8) 27 (16) 
Further/higher 
education 






35 (30) 23 (7) 
 
41 (22) 0.10 
Friend/partner 58 (50) 64 (20) 56 (30) 
Family 7 (6) 13 (4) 4 (2) 
 3 
  4 
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Table 2: Chi square/t-test analysis of relationship between age of first opportunity to use 1 
heroin and heroin-related outcomes 2 
Variable Whole sample 
% (N) 
 Early first 




opportunity to use 
heroin (≥18) 
% (N) 







Same day 65 (57) 64 (20) 65 (37) 0.98 
1-7 days 1 (1) 0 (0) 2 (1) 
1 week – 1 
month 
3 (3) 3 (1) 3 (2) 
Within a 
year 
11 (10) 13 (4) 10 (6) 
+1 year 19 (17) 19 (6) 19 (11) 
Heavy heroin use 36 (32) 43 (12) 31 (18) 0.28 
Overdose 55 (51) 74 (23) 46 (27) 0.01 
 Whole sample 
Mean (95% CI) 
Early first 
opportunity (≤17) 
Mean (95% CI) 
Later first 
opportunity (≥18) 
Mean (95% CI) 
T-test P 
value 
Age heroin use initiation 22.6 
(21.1 – 24.1) 
16.2  
(14.5 – 18.0) 
25.9 
(24.2 – 27.6) 
<0.001 
Age injecting onset 26.1  
(24.3 – 27.9) 
22.3 
(19.3 – 25.4) 
28.8 
(26.7 – 30.9) 
<0.001 
Age daily use onset 25.0 
(23.3 – 26.6) 
19.6 
(17.3 – 21.9) 
27.7 





Table 3: Regression coefficients (95% Confidence intervals) between age of first opportunity to use heroin and heroin-related outcomes 
1Adjusted for age at interview and age at heroin use initiation 
*P<0.05 **P<0.01 ***P<0.001  
 Overdose 
N=51 
Injecting onset (≤24 
N = 25 
Age of daily heroin use 
Univariate 
OR (95% CI) 
Multivariable1 
AOR (95% CI) 
Univariate 
OR (95% CI) 
Multivariable1 
AOR (95% CI) 
Univariate 
Beta (95% CI) 
Multivariable1 
Beta (95% CI) 
Later first opportunity to use 
heroin (≥18) 
N = 59 
1.00 1.00 1.00 1.00 0 0 
Early first opportunity to use 
heroin (≤17) 
N = 31 
3.41** 
(2.64 – 4.39) 
2.58*** 
 (1.40 – 4.76) 
7.77*** 
(6.08 – 9.92) 
0.81 
(0.29 – 2.22) 
-8.14* 
(-14.1 – -2.21) 
1.42 
(0.94 – 1.91) 
